• Home
  • About
  • Diagnostics
    • Ophthalmological
      • Overview
      • IgE Test
      • Lactoferrin Test
    • COVID-19 Testing Research
    • Other Areas
      • Oncological Diagnostics
      • New Test Development
  • Investors
    • Company Info
    • News
    • Media
    • Press Releases
    • SEC Filings
    • Corporate Governance
  • Contact

AXIM® Biotechnologies Receives Initial Order for Diagnostic Solutions as Exclusive Partner Verséa Ophthalmics Commences Initial Commercial Launch

by Kyle | Oct 4, 2022 | Press Release

SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare diagnostic solutions development company, announced today that it has received an initial order of 19,000...

AXIM® Biotechnologies Point-of-Care Diagnostic Test Platform Sales Commence With Verséa Ophthalmics’ Commercial Launch at AAO 2022

by Kyle | Sep 29, 2022 | Press Release

Sales of Point-of-Care Diagnostic Tests for Ocular Surface Disease Commence at the American Academy of Ophthalmology Annual Meeting Through Exclusive Partnership SAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,”...

AXIM® Biotechnologies Signs Exclusive Global Commercialization Agreement With Verséa™ Ophthalmics for Distribution and Sales of Novel Ophthalmic Diagnostics Solutions

by Kyle | Sep 19, 2022 | Press Release

SAN DIEGO, Sept. 19, 2022 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech” or “AXIM”), an international healthcare solutions company targeting ocular surface diseases, announced today that it has signed an exclusive global commercial...

Optometric Management: Perform a Pre-Fit Ocular Surface Evaluation

by Kyle | Jul 25, 2022 | News

The Rapid Quantitative Tear Test for MMP-9 from AXIM Biotechnologies Inc. was featured in a list of DED Diagnostic tools in Optometric Management.com. See the list below: DED Diagnostic Items* BLINK ASSESSMENT iPEDA Blink Analyzer MEIBOMIAN GLAND EXPRESSION Flexx MG...

AXIM Biotechnologies Celebrates Feature on the Vision is More Than 20/20™ Podcast

by Kyle | Jul 21, 2022 | Press Release

SAN DIEGO, July 21, 2022 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting ocular surface diseases, announced today that its CEO John Huemoeller has been...
« Older Entries
Next Entries »

About

Diagnostics

Investors

Contact

Success!

Subscribe

  • Follow
  • Follow